InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Berman Dennis N. Director active across 1 company, notably Inhibikase Therapeutics, Inc.. In total, 1 disclosures have been published. History available since 30 July 2026. The latest transaction was disclosed on 30 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条